HIGHLIGHTS OF PRESCRIBING INFORMATION …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEVZARA® safely and effectively. See full prescribing information for KEVZARA.
Download HIGHLIGHTS OF PRESCRIBING INFORMATION …
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
products.sanofi.us• To minimize the risk of hypoglycemia, titrate the dose of TOUJEO no more frequently than every 3 to 4 days. • Dosage adjustments may be needed with changes in physical activity, changes in meal patterns
HIGHLIGHTS OF PRESCRIBING INFORMATION …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUBAGIO® safely and effectively. See full prescribing information for AUBAGIO.
LEMTRADA (2.1) - Sanofi
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA.
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT.
HIGHLIGHTS OF PRESCRIBING INFORMATION Depression ...
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to useAMBIEN safely and effectively. See full prescribing information for AMBIEN
RIFADIN Rx Only Plasma concentrations after the 600 mg ...
products.sanofi.usRIFADIN® Rx Only (rifampin capsules USP) and RIFADIN® IV (rifampin for injection USP) To reduce the development of drug-resistant bacteria and maintain the effectiveness of
HIGHLIGHTS OF PRESCRIBING INFORMATION Infusion …
products.sanofi.usHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Fabrazyme safely and effectively. See full prescribing information for Fabrazyme.
HIGHLIGHTS OF PRESCRIBING INFORMATION Need to …
products.sanofi.usThe effect of AMBIEN may be slowed by ingestion with or immediately after a meal. 3 DOSAGE FORMS AND STRENGTHS AMBIEN is available in 5 mg and 10 mg strength tablets for oral administration. Tablets are not scored. AMBIEN 5 mg tablets are capsule-shaped, pink, film coated, with AMB 5 debossed on one side and 5401 on the other.
HIGHLIGHTS OF PRESCRIBING INFORMATION : Discontinue ...
products.sanofi.us• Maximum daily dosage is 60 units (60 units of insulin glargine and 20 mcg of lixisenatide). (2.1) • Discontinue basal insulin or GLP-1 receptor agonist prior to initiation. (2.2) • In patients naive to basal insulin or to a GLP-1 receptor agonist, currently on less than 30 units of basal insulin, or on a GLP-1 receptor agonist, the ...
Single-dose prefilled syringes: 30 mg/0.3 mL, 40 ... - Sanofi
products.sanofi.usanesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: • Use of indwelling epidural catheters
Related documents
Specialised Services Circular - shsc.nhs.uk
shsc.nhs.ukGeneral Practitioners on their role and responsibilities in prescribing hormone therapy for transgender and non-binary adults. In March 2016 the General Medical Council (GMC) published Guidance for Doctors
Focus on Antibiotic Prescribing - AWMSG
www.awmsg.orgCEPP National Audit Focus on Antibiotic Prescribing . March 2013 (updated June 2015)
Polypharmacy: Guidance for Prescribing - AWMSG
www.awmsg.orgPolypharmacy: Guidance for Prescribing Figure 1: Key Considerations for Prescribing in Frail Adults . July 2014
PRESCRIBING OF MEDICINES POLICY - East …
www.eastcheshire.nhs.uk2 Policy Title: Prescribing of Medicines Policy Executive Summary: This policy provides guidance to all staff in East Cheshire NHS Trust regarding all aspects of prescribing of medicines.
LITHIUM PRESCRIBING GUIDELINES - Welcome to …
www.iow.nhs.ukLithium prescribing guidelines August 2014 2 These guidelines have been produced to support the seamless transfer of lithium prescribing and
GUIDANCE FOR THE IMPLEMENTATION OF REPEAT …
www.nhsemployers.orgDecember 2013 Guidance for the implementation of repeat dispensing 2 Introduction Two thirds of prescriptions generated in primary care are for patients needing repeat …
Standards and Guidance for Pharmacist Prescribers …
www.psni.org.uk| P a g e 4 Background ‘Standards and Guidance for Pharmacist Prescribers’ (2013) replaces the 2009 Guidance. The updated Standards and Guidance provides more specific information around